🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. logo
Market Cap: High
Employees: Low

EDG-5506

Edgewise Therapeutics, Inc. is a biopharmaceutical company developing small molecule therapies for musculoskeletal diseases, including treatments for Duchenne muscular dystrophy and Becker muscular dystrophy.

Tags: Becker muscular dystrophy, Duchenne muscular dystrophy, biopharmaceutical, musculoskeletal diseases, small molecule therapies

Website

About | Leadership | Contact | Contact | Careers | About | About | About | About | About | About

Symbol: EWTX

Recent Price: $27.05

Industry: Biotechnology

CEO: Dr. Kevin Koch Ph.D.

Sector: Healthcare

Employees: 97

Address: 3415 Colorado Avenue, Boulder, CO 80303

Phone: 303 735 8373

Leadership

  • Kevin Koch, Ph.D., Director
  • Alan Russell, Ph.D., Director and Co-Founder
  • R. Michael Carruthers, Chief Financial Officer
  • Behrad Derakhshan, Ph.D., Chief Business Officer
  • Joanne M. Donovan, M.D., Ph.D., Chief Medical Officer
  • John Moore, General Counsel
  • Marc Semigran, M.D., Chief Development Officer
  • Peter Thompson, M.D., Chairman and Co-Founder
  • Laura Brege, Director
  • Badreddin Edris, Ph.D., Director and Co-Founder
  • Jonathan C. Fox, M.D., Ph.D., FACC, Director
  • Arlene Morris, Director
  • Jon Root, M.D., Director

Last updated: 2024-12-31